产品名称 | NebuSelect™ Recombinant Biotinylated Human CA125/MUC16, Avi-His-tag |
---|---|
目录号 | NBL-242276 |
别名 | CA125/MUC16; CA125; CA-125; CA125MUC-16; FLJ14303; MUC16 |
外观 | see COA |
分子量 | Gly12660-Met12923 |
CAS | N/A |
溶解度 | Water Soluble |
存储条件 | Short term 4℃; Long term -20℃. |
保存时间 | 2 years |
备注1 | Q8WXI7 |
备注2 |
目录号 | 规格 | 价格 | 库存状态 | |
NBL-242276-100ug | 100ug | Inquire | Inquire | |
NBL-242276-1mg | 1mg | Inquire | Inquire | |
NBL-242276-Customized Size | N/A | Inquire | Inquire |
Product Name:
NebuSelect™ Recombinant Biotinylated Human CA125/MUC16, Avi-His-tag
Catalog#:
NBL-242276
Description:
NebuSelect™ Recombinant Biotinylated Human CA125/MUC16, Avi-His-tag(Cat#NBL-242276) is expressed in HEK293 with His tag and Avi tag at the C-Terminus.It contains Gly12660-Met12923.
Species:
Human
Expression System:
HEK293
Molecular Weight:
The protein has a predicted MW of 31.3 kDa. Due to glycosylation, the protein migrates to 52-80 kDa based on Bis-Tris PAGE result.
Target Name:
CA125/MUC16; CA125; CA-125; CA125MUC-16; FLJ14303; MUC16
Target Information:
MUC16, also known as the CA125 antigen, is a mucin protein that may be found in type I transmembrane or secreted forms that are used monitor the progress of epithelial ovarian cancer therapy.Thought to provide a protective, lubricating barrier against particles and infectious agents at mucosal surfaces.Binding to MSLN mediates heterotypic cell adhesion. This may contribute to the metastasis of ovarian cancer to the peritoneum by initiating cell attachment to the mesothelial epithelium via binding to MSLN.
Amino Acid Sequence:
Gly12660-Met12923
Purity:
>95%
Formulation:
see COA
Endotoxin:
<1EU/ug(LAL Method)
Storage:
4°C for short term.
-20°C for long term.
To get more information, please contact us freely.